Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Disminución de las complicaciones gastrointestinales graves tras el uso de celecoxib: evidencia disponible en la bibliografía / Reduction of severe gastro-intestinal complications after use of colecoxib: evidence available in the literature
Soto, J; Romero, A.; Olivella, P.
Aten. prim. (Barc., Ed. impr.) ; 30(6): 415-415, oct. 2002.
Article in Es | IBECS | ID: ibc-16319

ABSTRACT

No disponible


Subject(s)
Humans , Sulfonamides , Evidence-Based Medicine , Anti-Inflammatory Agents, Non-Steroidal , Gastrointestinal Diseases , Severity of Illness Index
2.
New approaches to diagnosis and management of unstable angina and non-ST segment elevation myocardial infarction: controversial data.
Borja, J; Paz, M A; Olivella, P.
Arch Intern Med ; 162(4): 485-6, 2002 Feb 25.
Article in English | MEDLINE | ID: mdl-11863490

Subject(s)
Angina, Unstable/drug therapy , Anticoagulants/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Myocardial Infarction/drug therapy , Angina, Unstable/diagnosis , Electrocardiography , Humans , Myocardial Infarction/diagnosis , Research Design/standards
3.
[May drugs be a cost-effective investment in Spanish health system?]. / Son los medicamentos una inversión económicamente rentable para el sistema nacional de salud en España?
Soto, J; Olivella, P.
Med Clin (Barc) ; 117(16): 622-4, 2001 Nov 17.
Article in Spanish | MEDLINE | ID: mdl-11714470

Subject(s)
Drug Costs , Economics, Pharmaceutical , National Health Programs/economics , Cost-Benefit Analysis , Spain
4.
[Low-molecular weight heparins in the prophylaxis and treatment of pulmonary thromboembolism]. / Heparinas de bajo peso molecular en la profilaxis y tratamiento del tromboembolismo pulmonar.
Borja, J; Olivella, P.
Rev Esp Cardiol ; 54(9): 1121-2, 2001 Sep.
Article in Spanish | MEDLINE | ID: mdl-11535193

Subject(s)
Fibrinolytic Agents/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Practice Guidelines as Topic , Pulmonary Embolism/prevention & control , Dalteparin/therapeutic use , Humans , Pulmonary Embolism/drug therapy , Societies, Medical , Spain , United States , Venous Thrombosis/drug therapy , Venous Thrombosis/prevention & control
5.
[Dalteparin in the acute phase of unstable angina and non-Q-wave infarction]. / Dalteparina en la fase crónica de la angiona inestable e infarto sin onda Q.
Borja, J; Campbell, J; Olivella, P.
Rev Esp Cardiol ; 53(8): 1147-8, 2000 Aug.
Article in Spanish | MEDLINE | ID: mdl-11032539

Subject(s)
Angina, Unstable/drug therapy , Dalteparin/therapeutic use , Fibrinolytic Agents/therapeutic use , Myocardial Infarction/drug therapy , Acute Disease , Humans
6.
Concerning to low molecular weight heparins (LMWHs) in acut coronary syndromes.
Borja, J; Olivella, P.
S D J Med ; 53(7): 277-9, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10932610

Subject(s)
Coronary Disease/drug therapy , Dalteparin/therapeutic use , Fibrinolytic Agents/therapeutic use , Double-Blind Method , Female , Humans , Male
7.
[Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction]. / Heparina de bajo peso molecular en el tratamiento de los síndromes coronarios agudos sin elevación del segmento ST: angina inestable e infarto de miocardio sin onda Q.
Borja, J; Olivella, P.
Med Clin (Barc) ; 115(15): 583-6, 2000 Nov 04.
Article in Spanish | MEDLINE | ID: mdl-11141394

Subject(s)
Angina, Unstable/drug therapy , Anticoagulants/therapeutic use , Fibrinolytic Agents/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Myocardial Infarction/drug therapy , Angina, Unstable/mortality , Angina, Unstable/physiopathology , Anticoagulants/administration & dosage , Aspirin/administration & dosage , Aspirin/therapeutic use , Clinical Trials as Topic , Confidence Intervals , Dalteparin/administration & dosage , Dalteparin/therapeutic use , Data Interpretation, Statistical , Double-Blind Method , Electrocardiography , Enoxaparin/administration & dosage , Enoxaparin/therapeutic use , Female , Fibrinolytic Agents/administration & dosage , Heparin/administration & dosage , Heparin/therapeutic use , Heparin, Low-Molecular-Weight/administration & dosage , Humans , Male , Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Nadroparin/administration & dosage , Nadroparin/therapeutic use , Odds Ratio , Placebos , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use , Randomized Controlled Trials as Topic , Recurrence , Risk , Time Factors
8.
[Acute myocardial infarction in hospitalized patients]. / Infarto agudo de miocardio en pacientes hospitalizados.
Bros, R; Pérez Ayuso, M J; Cequier, A; Olivella, P; Gausí, C.
Med Clin (Barc) ; 81(8): 330-2, 1983 Sep 24.
Article in Spanish | MEDLINE | ID: mdl-6645684

Subject(s)
Myocardial Infarction , Aged , Angina, Unstable/physiopathology , Female , Hospitalization , Humans , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/drug therapy , Myocardial Infarction/physiopathology
9.
[Left ventricular function in mitral stenosis]. / Función ventricular izquierda en la estenosis mitral.
Olivella, P; Esplugas, E; Curós, A; Molina, C; Pujol, M.
Med Clin (Barc) ; 81(1): 7-9, 1983 Jun 11.
Article in Spanish | MEDLINE | ID: mdl-6888061

Subject(s)
Heart/physiopathology , Mitral Valve Stenosis/physiopathology , Adult , Female , Heart Ventricles/physiopathology , Hemodynamics , Humans , Male , Middle Aged , Stroke Volume
10.
[Prospective study of the nephrotoxicity of iodized contrast in patients undergoing cardiac catheterization]. / Estudio prospectivo de la nefrotoxicidad del contraste iodado en pacientes sometidos a cateterismo cardiaco.
Esplugas, E; Molina, C; Romero, R; Martínez Castelao, A; Anguera, N; Olivella, P.
Rev Esp Cardiol ; 36(4): 293-6, 1983.
Article in Spanish | MEDLINE | ID: mdl-6647956

Subject(s)
Acute Kidney Injury/chemically induced , Cardiac Catheterization , Diatrizoate Meglumine/adverse effects , Diatrizoate/analogs & derivatives , Iothalamate Meglumine/adverse effects , Cardiac Catheterization/adverse effects , Female , Humans , Male , Prospective Studies
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL